Table 2 Adverse effects of mogamulizumab administration.

From: Depletion of central memory CD8+ T cells might impede the antitumor therapeutic effect of Mogamulizumab

 

0.1 mg/kg (n = 20)

1.0 mg/kg (n = 19)

Total (n = 39)

Cases

Events

Cases

Events

Cases

Events

AEs

20

198

19

126

39

324

Related AE

19

65

17

49

36

114

  Grade 1/2/3/4

16/12/6/1

34/23/7/1

10/14/4/2

23/20/4/2

26/26/10/3

57/43/11/3

  *: Overlapping

*

 

*

 

*

 

decreased lymphocytes

 

15

 

11

 

25

  Grade 1/2/3/4

 

1/10/3/1

 

0/7/2/2

 

1/17/4/3

dermal disorders

 

15

 

11

 

26

  Grade 1/2/3/4

 

9/5/1/0

 

5/6/0/0

 

14/11/1/0

Drug eruption, Grade 2

   

1

 

1

Asteatotic eczema, Grade 1

 

1

   

1

Erythema, Grade 1

 

1

   

1

Papule, Grade 2

   

1

 

1

Pruritus, Grade 1

 

1

   

1

Rash, Grade 1/2

 

1/4

 

2/3

 

3/7

Rash maculo-papular, Grade 1/2/3

 

5/1/1

 

3/1/0

 

8/2/1

other adverse effects

      

increased alanine aminotransferase,

Grade 1/3

 

3/0/1

  

3/0/1

 

decreased appetite,

Grade 1

   

1

 

1

increased aspartate aminotransferase, Grade 1/3

 

2/0/1

  

2/0/1

 

Hypophosphatasemia, Grade 3

   

1

 

0/0/3

increased gamma-glutamyl transferase, Grade 3

 

1

   

0/0/3

hypophosphatasemia, Grade 1

 

1

   

1